March 25, 2025
Willkie is advising ProAssurance Corporation (NYSE: PRA), an industry-leading specialty insurer with extensive expertise in medical liability and products liability for medical technology and life sciences, on regulatory aspects of its sale to The Doctors Company, the nation’s largest physician-owned medical malpractice insurer, for approximately $1.3 billion.
On March 19, The Doctors Company and ProAssurance announced that they entered into a definitive agreement under which ProAssurance will be acquired by The Doctors Company for $25.00 per share in cash. The transaction is valued at approximately $1.3 billion and will create a combined company with assets of approximately $12 billion.
The transaction is expected to close in the first half of 2026, and is subject to customary closing conditions, including approval by ProAssurance’s stockholders.
The Willkie team is led by partner Kara Baysinger and includes associates Melissa Khajaei and Brendan Smith.
On March 19, The Doctors Company and ProAssurance announced that they entered into a definitive agreement under which ProAssurance will be acquired by The Doctors Company for $25.00 per share in cash. The transaction is valued at approximately $1.3 billion and will create a combined company with assets of approximately $12 billion.
The transaction is expected to close in the first half of 2026, and is subject to customary closing conditions, including approval by ProAssurance’s stockholders.
The Willkie team is led by partner Kara Baysinger and includes associates Melissa Khajaei and Brendan Smith.
